all report title image
  • Published In : Nov 2023
  • Code : CMI5938
  • Pages : 160
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Dosage Form
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers, Acquisitions, and Collaborations
  4. Global Nifedipine Medication Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Nifedipine Medication Market, By Dosage Form, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 - 2030
      • Segment Trends
    • Tablets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Extended-Release Tablets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Capsules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Others (Sublingual tablets/spray, Patches and Others)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  6. Global Nifedipine Medication Market, By Indication, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 - 2030
      • Segment Trends
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Angina Pectoris
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Raynaud's Phenomenon
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Others (Pre-term labor, vasospastic conditions and Others)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  7. Global Nifedipine Medication Market, By Distribution Channel, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 - 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  8. 8. Global Nifedipine Medication Market, By Region, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Sub-region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Sub-region, 2019 –2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Mn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape
    • Company Profile
      • Pfizer Inc
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • AstraZeneca PLC
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mylan N.V.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sanofi S.A.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline plc.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Lupin Limited
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sandoz International GmbH (a Novartis division)
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Dr. Reddy's Laboratories Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Torrent Pharmaceuticals Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Apotex Inc.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us

*Browse 35 market data tables and 33 figures on "Global Nifedipine Medication Market” – Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo